Publications of Gerhard Rammes

Domenici, M. R.; Azad, S. C.; Marsicano, G.; Schierloh, A.; Wotjak, C. T.; Dodt, H.-U.; Zieglgänsberger, W.; Lutz, B.; Rammes, G.: Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamergic synaptic transmission. The Journal of Neuroscience 26 (21), pp. 5794 - 5799 (2006)

Eisensamer, B.; Uhr, M.; Meyr, S.; Gimpl, G.; Deiml, T.; Rammes, G.; Lambert, J. J.; Zieglgänsberger, W.; Holsboer, F.; Rupprecht, R.: Antidepressants and antipsychotic drugs colocalize with 5-HT₃ receptors in raft-like domains. The Journal of Neuroscience 25 (44), pp. 10198 - 10206 (2005)

Azad, S. C.; Huge, V.; Schöps, P.; Hilf, C.; Beyer, A.; Dodt, H.-U.; Rammes, G.; Zieglgänsberger, W.: Endogenes Cannabinoidsystem. Einfluss auf neuronale Plastizität und Schmerzgedächtnis. Schmerz 19 (6), pp. 521 - 527 (2005)

Azad, S. C.; Eder, M.; Simon, W.; Hapfelmeier, G.; Dodt, H. U.; Zieglgänsberger, W.; Rammes, G.: The potassium channel modulator flupirtine shifts the frequency-response function of hippocampal synapses to favour LTD in mice. Neuroscience Letters 370 (2-3), pp. 186 - 190 (2004)

Azad, S. C.; Monory, K.; Marsicano, G.; Cravatt, B. F.; Lutz, B.; Zieglgänsberger, W.; Rammes, G.: Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling. Journal of Neuroscience 24 (44), pp. 9953 - 9961 (2004)

Müller, T.; Glass, J.; Müller, D.; Link, A.; Schenk, C.; Rammes, G.: A new galenic formulation of selegiline (Xilopae) in the treatment of Parkinson disease. Aktuelle Neurologie 31 (7), pp. 347 - 352 (2004)

Rammes, G.; Eisensamer, B.; Ferrari, U.; Shapa, M.; Gimpl, G.; Gilling, K.; Parsons, C.; Riering, K.; Hapfelmeier, G.; Bondy, B. et al.; Zieglgänsberger, W.; Holsboer, F.; Rupprecht, R.: Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner. Molecular Psychiatry 9 (9), pp. 846 - 858 (2004)

Deiml, T.; Haseneder, R.; Zieglgänsberger, W.; Rammes, G.; Eisensamer, B.; Rupprecht, R.; Hapfelmeier, G.: α-Thujone reduces 5-HT3 receptor activity by an effect on the anonist-induced desensitization. Neuropharmacology 46, pp. 192 - 201 (2004)

Haseneder, R.; Kurz, J.; Dodt, H.-U. U.; Kochs, E.; Zieglgänsberger, W.; Scheller, M.; Rammes, G.; Hapfelmeier, G.: Isoflurane Reduces Glutamatergic Transmission in Neurons in the Spinal Cord Superficial Dorsal Horn: Evidence for a Presynaptic Site of an Analgesic Action. Anesthesia and Analgesia 98, pp. 1718 - 1723 (2004)

Rammes, G.; Eisensamer, B.; Ferrari, U.; Shapa, M.; Gimpl, G.; Gilling, K.; Parsons, C.; Riering, K.; Hapfelmeier, G.; Bondy, B. et al.; Zieglgänsberger, W.; Holsboer, F.; Rupprecht, R.: Antipsychotic drugs antagonize human serotonin type 3 (5-HT₃) receptor currents in a noncompetitive manner [Image]. Molecular Psychiatry 9 (9), p. 818 - 818 (2004)

Eisensamer, B.; Rammes, G.; Gimpl, G.; Shapa, M.; Ferrari, U.; Hapfelmeier, G.; Bondy, B.; Parsons, C.; Gilling, K.; Zieglgänsberger, W. et al.; Holsboer, F.; Rupprecht, R.: Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor. Pharmacopsychiatry 36 (5), p. 223 - 223 (2003)

DeBock, F.; Kurz, J.; Azad, S. C.; Parsons, C. G.; Hapfelmeier, G.; Zieglgänsberger, W.; Rammes, G.: alpha(2)-Adrenoreceptor activation inhibits LTP and LTD in the basolateral amygdala: involvement of G(i/o)-protein-mediated modulation of Ca2+-channels and inwardly rectifying K+-channels in LTD. European Journal of Neuroscience 17 (7), pp. 1411 - 1424 (2003)

Azad, S. C.; Eder, M.; Marsicano, G.; Lutz, B.; Zieglgänsberger, W.; Rammes, G.: Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse. Learning & Memory 10 (2), pp. 116 - 128 (2003)

Hapfelmeier, G.; Tredt, C.; Haseneder, R.; Zieglgänsberger, W.; Eisensamer, B.; Rupprecht, R.; Rammes, G.: Co-expression of the 5-HT3B serotonin receptor subunit alters the biophysics of the 5-HT3 receptor. Biophysical Journal 84 (3), pp. 1720 - 1733 (2003)

Rammes, G.; Palmer, M.; Eder, M.; Dodt, H. U.; Zieglgänsberger, W.; Collingridge, G. L.: Activation of mGlu receptors induces LTD without affecting postsynaptic sensitivity of CA1 neurons in rat hippocampal slices. Journal of Physiology-London 546 (2), pp. 455 - 460 (2003)

Eder, M.; Becker, K.; Rammes, G.; Schierloh, A.; Azad, S. C.; Zieglgänsberger, W.; Dodt, H.-U.: Distribution and properties of functional postsynaptic kainate receptors on neocortical layer V pyramidal neurons. The Journal of Neuroscience 23 (16), pp. 6660 - 6670 (2003)

Eisensamer, B.; Rammes, G.; Gimpl, G.; Shapa, M.; Ferrari, U.; Hapfelmeier, G.; Bondy, B.; Parsons, C.; Gilling, K.; Zieglgänsberger, W. et al.; Holsboer, F.; Rupprecht, R.: Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor. Molecular Psychiatry 8 (12), pp. 994 - 1007 (2003)

Haseneder, R.; Rammes, G.; Zieglgänsberger, W.; Kochs, E.; Hapfelmeier, G.: GABA_A receptor activitation and open-channel block by volatile anaesthetics: a new principle of receptor modulation? European Journal of Pharmacology 451, pp. 43 - 50 (2002)

Eder, M.; Rammes, G.; Zieglgänsberger, W.; Dodt, H.-U.: GABA_A and GABA_B receptors on neocortical neurons are differentially distributed. European Journal of Neuroscience 13, pp. 1065 - 1069 (2001)

Hapfelmeier, G.; Haseneder, R.; Eder, M.; Adelsberger, H.; Kochs, E.; Rammes, G.; Zieglgänsberger, W.: Isoflurane slows inactivation kinetics of rat recombinant α₁β₂γ_2L GABA_A receptors: enhancement of GABAergic transmission despite an open-channel block. Neuroscience Letters 307, pp. 97 - 100 (2001)